Ryan Drant

Ryan currently serves as Industry Advisor with Catalys Pacific and is Founder and Managing Director of Questa Capital, a healthcare-focused venture capital and growth equity investment firm. From 1996 through 2015, Ryan was a partner at New Enterprise Associates, where he served as a general partner, Head of Healthcare Investing and a member of the NEA Management Committee.

Prior to NEA, he worked in the corporate finance group at Alex. Brown & Sons and was a consultant at Arthur Andersen & Co. He represents Questa on the board of directors of Cortica, Dispatch Health, Eximis Surgical, Intrinsic Therapeutics, and Medrio. He has previously served on the boards of more than 30 private companies including Epix Therapeutics, Cartiva, NeoTract, Radiology Partners, DSI Renal, Ulthera, Acclarent, Proxima Therapeutics and FoxHollow.

Ryan also serves on the board of the Medical Device Manufacturers Association (MDMA) and the National Venture Capital Association (NVCA) and is a four-time nominee to the Forbes Midas List of top venture capital investors. He received a Bachelor of Arts degree in Political Science from Stanford University.